• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Editorial
Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind
Beom Kyung Kim1,2,3
1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea
2Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Republic of Korea
3Yonsei Liver Center, Severance Hospital, Seoul, Republic of Korea
Correspondence :  Beom Kyung Kim ,
Tel: 82-2-2228-1930, Fax: 82-2-393-6884, Email: beomkkim@yuhs.ac
Received: June 30, 2024   Accepted: July 7, 2024
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 118 View
  • 3 Download
Related articles

Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients2023 July;29(3)

Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea2009 March;15(1)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 566
TOTAL : 1931669
Close layer